Cargando…
Dapagliflozin protects against nonalcoholic steatohepatitis in db/db mice
Nonalcoholic fatty liver disease (NAFLD), which is the most common liver disease, is associated with type 2 diabetes mellitus and metabolic syndrome. Although there is no consensus on the treatment of NAFLD, growing evidence suggests that tight glycemic control would contribute to the improvement of...
Autores principales: | Qiao, Panshuang, Jia, Yingli, Ma, Ang, He, Jinzhao, Shao, Chen, Li, Xiaowei, Wang, Shuyuan, Yang, Baoxue, Zhou, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437261/ https://www.ncbi.nlm.nih.gov/pubmed/36059948 http://dx.doi.org/10.3389/fphar.2022.934136 |
Ejemplares similares
-
Dapagliflozin Ameliorates Diabetic Kidney Disease via Upregulating Crry and Alleviating Complement Over-activation in db/db Mice
por: Chang, Dong-Yuan, et al.
Publicado: (2021) -
Protective Effects and Mechanisms of Polyethylene Glycol Loxenatide Against Hyperglycemia and Liver Injury in db/db diabetic Mice
por: Zhang, Yu, et al.
Publicado: (2021) -
Gut microbiota mediated hypoglycemic effect of Astragalus membranaceus polysaccharides in db/db mice
por: Song, Qianbo, et al.
Publicado: (2022) -
The Hypoglycemic and Renal Protection Properties of Crocin via Oxidative Stress-Regulated NF-κB Signaling in db/db Mice
por: Qiu, Ye, et al.
Publicado: (2020) -
MG53 Does Not Manifest the Development of Diabetes in db/db Mice
por: Wang, Qiang, et al.
Publicado: (2020)